Atlas Capital Advisors’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.52K Sell
275
-87
-24% -$3.09K ﹤0.01% 815
2025
Q4
$15.1K Buy
+362
New +$14.7K ﹤0.01% 731
2025
Q2
$59.6K Buy
+1,127
New +$59.5K 0.01% 600
2023
Q1
Sell
-35
Closed -$4.66K 912
2022
Q4
$4.66K Hold
35
﹤0.01% 791
2022
Q3
$3.91K Hold
35
﹤0.01% 793
2022
Q2
$4.75K Hold
35
﹤0.01% 852
2022
Q1
$5.83K Buy
35
+33
+1,650% +$6.27K ﹤0.01% 780
2021
Q4
$357 Hold
2
﹤0.01% 909
2021
Q3
$354 Hold
2
﹤0.01% 923
2021
Q2
$321 Buy
+2
New +$308 ﹤0.01% 935

Other funds holding CNXC

Atlas Capital Advisors's CNXC Position: Q1 2026 in Review

Atlas Capital Advisors reduced its Concentrix (CNXC) stake by 24% in Q1 2026, selling an estimated $3.09K and leaving 275 shares worth $7.52K. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Atlas Capital Advisors first reported a position in CNXC in Q2 2021 and has held it in 10 quarters since. The position peaked at $59.6K in Q2 2025. 301 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • Atlas Capital Advisors held 275 shares of Concentrix worth $7.52K as of Q1 2026.
  • Atlas Capital Advisors sold 87 Concentrix shares in Q1 2026, an estimated $3.09K.
  • Concentrix made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q1 2026, its #815 holding.
  • Atlas Capital Advisors first reported a position in Concentrix in Q2 2021 and has held it in 10 quarters since.
  • Atlas Capital Advisors's Concentrix position peaked at $59.6K in Q2 2025.
  • 301 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Atlas Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.